(S)-naringenin multiple interactions ISO WT1 (Homo sapiens) 6480464 [naringenin co-treated with bisphenol A] results in increased expression of WT1 mRNA and [naringenin metabolite co-treated with bisphenol A] results in increased expression of WT1 mRNA CTD PMID:36235125 (S)-naringenin increases expression ISO WT1 (Homo sapiens) 6480464 naringenin metabolite results in increased expression of WT1 mRNA CTD PMID:36235125 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO WT1 (Homo sapiens) 6480464 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of WT1 mRNA CTD PMID:22101062 17beta-estradiol decreases response to substance ISO WT1 (Homo sapiens) 6480464 WT1 protein results in decreased susceptibility to Estradiol CTD PMID:20204298 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Wt1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of WT1 mRNA CTD PMID:19933214 and PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of WT1 mRNA CTD PMID:34747641 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of WT1 mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of WT1 mRNA CTD PMID:19643169 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 4,4'-sulfonyldiphenol increases expression ISO Wt1 (Mus musculus) 6480464 bisphenol S results in increased expression of WT1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO Wt1 (Mus musculus) 6480464 bisphenol S affects the methylation of WT1 gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO WT1 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of WT1 gene CTD PMID:31601247 4,4'-sulfonyldiphenol increases methylation ISO Wt1 (Mus musculus) 6480464 bisphenol S results in increased methylation of WT1 exon CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO Wt1 (Mus musculus) 6480464 Fenretinide results in increased expression of WT1 mRNA CTD PMID:28973697 5-fluorouracil decreases expression ISO Wt1 (Mus musculus) 6480464 Fluorouracil results in decreased expression of WT1 protein CTD PMID:21296659 acetic acid increases expression ISO Wt1 (Mus musculus) 6480464 Acetic Acid results in increased expression of WT1 protein CTD PMID:21296659 all-trans-retinoic acid multiple interactions ISO WT1 (Homo sapiens) 6480464 PDCD4 protein promotes the reaction [Tretinoin results in decreased expression of WT1 protein] CTD PMID:17259349 all-trans-retinoic acid decreases expression ISO WT1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of WT1 mRNA more ... CTD PMID:15749674 more ... all-trans-retinoic acid increases expression ISO Wt1 (Mus musculus) 6480464 Tretinoin results in increased expression of WT1 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression ISO Wt1 (Mus musculus) 6480464 Tretinoin results in decreased expression of WT1 protein CTD PMID:15855632 all-trans-retinoic acid increases expression ISO WT1 (Homo sapiens) 6480464 Tretinoin results in increased expression of WT1 mRNA and Tretinoin results in increased expression of WT1 protein CTD PMID:12644474 more ... allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA CTD PMID:34896426 and PMID:36053783 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of WT1 mRNA CTD PMID:16483693 amphibole asbestos increases expression EXP 6480464 Asbestos and Amphibole results in increased expression of WT1 mRNA CTD PMID:22251266 arsenite(3-) increases methylation ISO WT1 (Homo sapiens) 6480464 arsenite results in increased methylation of WT1 promoter CTD PMID:23974009 arsenous acid decreases expression ISO WT1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of WT1 mRNA and Arsenic Trioxide results in decreased expression of WT1 protein CTD PMID:16966277 and PMID:20471514 arsenous acid increases expression ISO WT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of WT1 mRNA CTD PMID:11940349 atorvastatin calcium multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein] CTD PMID:34939712 atrazine decreases expression ISO Wt1 (Mus musculus) 6480464 Atrazine results in decreased expression of WT1 mRNA CTD PMID:33463082 benzo[a]pyrene multiple interactions ISO Wt1 (Mus musculus) 6480464 AHR affects the reaction [Benzo(a)pyrene affects the splicing of WT1 mRNA] CTD PMID:21803694 benzo[a]pyrene increases methylation ISO WT1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of WT1 exon and Benzo(a)pyrene results in increased methylation of WT1 promoter CTD PMID:27901495 benzo[a]pyrene affects splicing ISO Wt1 (Mus musculus) 6480464 Benzo(a)pyrene affects the splicing of WT1 mRNA CTD PMID:21803694 benzo[e]pyrene decreases methylation ISO WT1 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of WT1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA and [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of WT1 mRNA CTD PMID:25031359 and PMID:31199487 bisdemethoxycurcumin decreases expression ISO WT1 (Homo sapiens) 6480464 bisdemethoxycurcumin results in decreased expression of WT1 mRNA and bisdemethoxycurcumin results in decreased expression of WT1 protein CTD PMID:18034345 bisphenol A decreases expression ISO Wt1 (Mus musculus) 6480464 bisphenol A results in decreased expression of WT1 mRNA and bisphenol A results in decreased expression of WT1 protein CTD PMID:25434310 bisphenol A increases expression ISO Wt1 (Mus musculus) 6480464 bisphenol A results in increased expression of WT1 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO WT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WT1 gene more ... CTD PMID:31601247 more ... bisphenol A increases methylation ISO WT1 (Homo sapiens) 6480464 bisphenol A results in increased methylation of WT1 gene CTD PMID:31601247 bisphenol A affects methylation ISO Wt1 (Mus musculus) 6480464 bisphenol A affects the methylation of WT1 promoter CTD PMID:27334623 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of WT1 mRNA CTD PMID:25181051 bisphenol F increases expression ISO Wt1 (Mus musculus) 6480464 bisphenol F results in increased expression of WT1 mRNA CTD PMID:30951980 bortezomib decreases expression ISO WT1 (Homo sapiens) 6480464 Bortezomib results in decreased expression of WT1 mRNA and Bortezomib results in decreased expression of WT1 protein CTD PMID:17629554 more ... bromochloroacetic acid decreases expression ISO Wt1 (Mus musculus) 6480464 bromochloroacetic acid results in decreased expression of WT1 protein CTD PMID:21296659 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 cadmium atom decreases expression ISO Wt1 (Mus musculus) 6480464 Cadmium results in decreased expression of WT1 protein CTD PMID:37506864 cadmium atom multiple interactions ISO Wt1 (Mus musculus) 6480464 Cadmium promotes the reaction [ATG5 protein affects the expression of WT1 protein] and WT1 protein inhibits the reaction [Cadmium results in decreased expression of ALDH1A1 protein] CTD PMID:37506864 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of WT1 mRNA and Caffeine results in decreased expression of WT1 protein CTD PMID:31306741 cannabidiol decreases expression ISO WT1 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of WT1 mRNA and Cannabidiol results in decreased expression of WT1 protein CTD PMID:34871667 cannabidiol decreases expression ISO Wt1 (Mus musculus) 6480464 Cannabidiol results in decreased expression of WT1 mRNA and Cannabidiol results in decreased expression of WT1 protein CTD PMID:34871667 carbamazepine affects expression ISO WT1 (Homo sapiens) 6480464 Carbamazepine affects the expression of WT1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Wt1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carmustine decreases response to substance ISO WT1 (Homo sapiens) 6480464 WT1 results in decreased susceptibility to Carmustine CTD PMID:20820871 CGP 52608 multiple interactions ISO WT1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to WT1 gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of WT1 mRNA CTD PMID:23125180 chrysene increases expression ISO Wt1 (Mus musculus) 6480464 chrysene results in increased expression of WT1 mRNA CTD PMID:26377693 cisplatin decreases response to substance ISO WT1 (Homo sapiens) 6480464 WT1 results in decreased susceptibility to Cisplatin CTD PMID:20820871 cobalt dichloride multiple interactions ISO WT1 (Homo sapiens) 6480464 [cobaltous chloride co-treated with Deferoxamine] results in increased expression of WT1 mRNA CTD PMID:12738801 colforsin daropate hydrochloride increases expression ISO WT1 (Homo sapiens) 6480464 Colforsin results in increased expression of WT1 mRNA CTD PMID:15961562 copper atom multiple interactions ISO WT1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of WT1 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of WT1 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO WT1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of WT1 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of WT1 mRNA CTD PMID:30556269 corticosterone decreases expression EXP 6480464 Corticosterone results in decreased expression of WT1 mRNA and Corticosterone results in decreased expression of WT1 protein CTD PMID:31306741 crocidolite asbestos increases expression ISO Wt1 (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of WT1 mRNA CTD PMID:23917077 and PMID:29279043 curcumin decreases expression ISO WT1 (Homo sapiens) 6480464 Curcumin results in decreased expression of WT1 mRNA and Curcumin results in decreased expression of WT1 protein CTD PMID:18034345 and PMID:19196508 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA CTD PMID:34896426 and PMID:36053783 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA CTD PMID:34896426 and PMID:36053783 dapagliflozin multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein] CTD PMID:34939712 demethoxycurcumin decreases expression ISO WT1 (Homo sapiens) 6480464 demethoxycurcumin results in decreased expression of WT1 mRNA and demethoxycurcumin results in decreased expression of WT1 protein CTD PMID:18034345 desferrioxamine B multiple interactions ISO WT1 (Homo sapiens) 6480464 [cobaltous chloride co-treated with Deferoxamine] results in increased expression of WT1 mRNA CTD PMID:12738801 dexamethasone increases expression ISO Wt1 (Mus musculus) 6480464 Dexamethasone results in increased expression of WT1 mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO WT1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of WT1 mRNA CTD PMID:11940349 diarsenic trioxide decreases expression ISO WT1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of WT1 mRNA and Arsenic Trioxide results in decreased expression of WT1 protein CTD PMID:16966277 and PMID:20471514 diazinon affects expression EXP 6480464 Diazinon affects the expression of WT1 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression ISO Wt1 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of WT1 mRNA and Dibutyl Phthalate results in decreased expression of WT1 protein CTD PMID:25434310 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of WT1 mRNA CTD PMID:22546817 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of WT1 mRNA CTD PMID:36653537 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of WT1 mRNA CTD PMID:31199487 dioxygen increases expression ISO WT1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of WT1 mRNA CTD PMID:12738801 dioxygen decreases expression ISO WT1 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of WT1 mRNA CTD PMID:17175027 diuron decreases expression EXP 6480464 Diuron results in decreased expression of WT1 mRNA CTD PMID:21551480 and PMID:25152437 ergosta-4,6,8(14),22-tetraen-3-one multiple interactions ISO Wt1 (Mus musculus) 6480464 ergosta-4 more ... CTD PMID:28578904 ethanol multiple interactions EXP 6480464 Ethanol affects the reaction [Dietary Fats affects the expression of WT1 protein] CTD PMID:31811911 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA and [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA CTD PMID:34896426 and PMID:36053783 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of WT1 mRNA CTD PMID:18035473 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of WT1 mRNA CTD PMID:12679049 fructose multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein] and [Dietary Fats co-treated with Fructose] results in decreased expression of WT1 protein CTD PMID:34939712 fulvestrant decreases response to substance ISO WT1 (Homo sapiens) 6480464 WT1 protein results in decreased susceptibility to fulvestrant CTD PMID:20204298 fulvestrant multiple interactions ISO WT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of WT1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of WT1 mRNA CTD PMID:27387713 genistein multiple interactions EXP 6480464 [Diethylhexyl Phthalate co-treated with Genistein] results in decreased expression of WT1 mRNA CTD PMID:25031359 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of WT1 mRNA CTD PMID:22061828 Indeno[1,2,3-cd]pyrene decreases expression ISO Wt1 (Mus musculus) 6480464 indeno(1 more ... CTD PMID:26377693 lead(0) affects methylation ISO WT1 (Homo sapiens) 6480464 Lead affects the methylation of WT1 gene CTD PMID:31636367 lipopolysaccharide increases expression ISO WT1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of WT1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO WT1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of WT1 mRNA CTD PMID:35811015 losartan multiple interactions ISO Wt1 (Mus musculus) 6480464 Losartan inhibits the reaction [AGT protein results in decreased expression of WT1 protein] CTD PMID:28578904 malathion increases expression ISO WT1 (Homo sapiens) 6480464 Malathion results in increased expression of WT1 mRNA CTD PMID:32069766 manganese atom decreases expression ISO WT1 (Homo sapiens) 6480464 Manganese results in decreased expression of WT1 mRNA CTD PMID:17175027 manganese(0) decreases expression ISO WT1 (Homo sapiens) 6480464 Manganese results in decreased expression of WT1 mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO WT1 (Homo sapiens) 6480464 manganese chloride results in decreased expression of WT1 mRNA CTD PMID:17175027 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 methapyrilene decreases methylation ISO WT1 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of WT1 intron CTD PMID:30157460 nickel subsulfide decreases expression ISO Wt1 (Mus musculus) 6480464 nickel subsulfide results in decreased expression of WT1 mRNA CTD PMID:12729255 nitric oxide increases expression EXP 6480464 Nitric Oxide results in increased expression of WT1 mRNA CTD PMID:21443142 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of WT1 mRNA and nitrofen results in decreased expression of WT1 protein CTD PMID:21072664 Pachymic acid multiple interactions ISO Wt1 (Mus musculus) 6480464 pachymic acid analog inhibits the reaction [AGT protein results in decreased expression of WT1 protein] CTD PMID:28578904 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of WT1 mRNA CTD PMID:33387578 paraquat increases expression ISO Wt1 (Mus musculus) 6480464 Paraquat results in increased expression of WT1 mRNA CTD PMID:16797015 perfluorohexanesulfonic acid increases expression ISO Wt1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of WT1 mRNA CTD PMID:37995155 perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of WT1 mRNA and perfluoro-n-nonanoic acid results in increased expression of WT1 protein CTD PMID:20580666 potassium dichromate increases expression ISO Wt1 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of WT1 mRNA CTD PMID:23608068 progesterone increases expression ISO WT1 (Homo sapiens) 6480464 Progesterone results in increased expression of WT1 mRNA more ... CTD PMID:14662165 prostaglandin E2 multiple interactions ISO WT1 (Homo sapiens) 6480464 Dinoprostone inhibits the reaction [WT1 protein binds to CYP19A1 promoter] and Dinoprostone inhibits the reaction [WT1 protein binds to STAR promoter] CTD PMID:19001523 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of WT1 mRNA CTD PMID:23358152 pyrethrins increases expression EXP 6480464 Pyrethrins results in increased expression of WT1 mRNA CTD PMID:36053783 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of WT1 mRNA CTD PMID:34896426 quercetin increases expression ISO WT1 (Homo sapiens) 6480464 Quercetin results in increased expression of WT1 mRNA CTD PMID:36982678 quercetin multiple interactions ISO WT1 (Homo sapiens) 6480464 [bisphenol A co-treated with Quercetin metabolite] results in increased expression of WT1 mRNA and [bisphenol A co-treated with Quercetin] results in increased expression of WT1 mRNA CTD PMID:36982678 resmethrin increases expression ISO Wt1 (Mus musculus) 6480464 resmethrin results in increased expression of WT1 mRNA CTD PMID:31593228 resveratrol multiple interactions ISO WT1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of WT1 mRNA CTD PMID:23557933 rosuvastatin calcium increases expression EXP 6480464 Rosuvastatin Calcium results in increased expression of WT1 mRNA CTD PMID:21443142 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO WT1 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of WT1 mRNA CTD PMID:35811015 sirolimus decreases expression ISO WT1 (Homo sapiens) 6480464 Sirolimus results in decreased expression of WT1 mRNA more ... CTD PMID:15782132 and PMID:18927120 sodium arsenite decreases expression ISO WT1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of WT1 mRNA and sodium arsenite results in decreased expression of WT1 protein CTD PMID:16966277 sodium arsenite multiple interactions ISO WT1 (Homo sapiens) 6480464 [Oligodeoxyribonucleotides more ... CTD PMID:29277653 and PMID:30090327 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of WT1 mRNA and sodium arsenite results in increased expression of WT1 protein CTD PMID:11241755 and PMID:16876216 sodium arsenite affects expression EXP 6480464 sodium arsenite affects the expression of WT1 mRNA CTD PMID:23137061 sodium arsenite increases expression ISO WT1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of WT1 mRNA and sodium arsenite results in increased expression of WT1 protein CTD PMID:12016162 more ... spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of WT1 protein CTD PMID:30734886 staurosporine increases expression ISO WT1 (Homo sapiens) 6480464 Staurosporine results in increased expression of WT1 protein CTD PMID:12914969 tamoxifen decreases response to substance ISO WT1 (Homo sapiens) 6480464 WT1 protein results in decreased susceptibility to Tamoxifen CTD PMID:20204298 and PMID:20944147 tetrachloromethane affects expression ISO Wt1 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of WT1 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of WT1 mRNA CTD PMID:31150632 tetraphene decreases expression ISO Wt1 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of WT1 mRNA CTD PMID:26377693 Theaflavin 3,3'-digallate affects expression ISO WT1 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of WT1 mRNA CTD PMID:34925699 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of WT1 mRNA CTD PMID:34492290 trichostatin A increases expression ISO WT1 (Homo sapiens) 6480464 trichostatin A results in increased expression of WT1 mRNA CTD PMID:24935251 triclosan increases expression ISO WT1 (Homo sapiens) 6480464 Triclosan results in increased expression of WT1 mRNA CTD PMID:30510588 triphenylstannane decreases expression EXP 6480464 triphenyltin results in decreased expression of WT1 mRNA CTD PMID:35489455 valproic acid multiple interactions ISO WT1 (Homo sapiens) 6480464 CEBPA protein affects the reaction [Valproic Acid results in increased expression of WT1 mRNA] CTD PMID:32623605 valproic acid increases expression ISO WT1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of WT1 mRNA CTD PMID:28001369 and PMID:32623605 valproic acid decreases methylation ISO WT1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of WT1 gene CTD PMID:29154799 vitamin E affects expression EXP 6480464 Vitamin E affects the expression of WT1 mRNA CTD PMID:15370891 zearalenone decreases expression ISO Wt1 (Mus musculus) 6480464 Zearalenone results in decreased expression of WT1 mRNA CTD PMID:24412631